In conclusion, CYFR21 and CEA were elevated in patients with LC and could potentially be used as effective single serum biomarkers for the diagnosis of NSCLC, while NSE and CEA were the most sensitive for the diagnosis of SCLC. The gene discussed is CEACAM5; the disease is small cell lung carcinoma.